In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


McNeil Rx Nicotrol Inhaler has six-month limit to recommended treatment duration.

This article was originally published in The Tan Sheet

Executive Summary

MCNEIL NICOTROL INHALER Rx TREATMENT DURATION IS SIX MONTHS, the company said following FDA approval of the nicotine inhalation system May 2. "After initial treatment period (up to 12 weeks), the patient is recommended to begin a gradual reduction of dosage. Total treatment should not exceed six months," the Johnson & Johnson subsidiary said. FDA approval came one year after the NDA was submitted on May 1, 1996.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts